Skip to content

Study on intervention of people with Pre diabetes and Dampness Syndrome

Study on intervention of people with Pre diabetes and Dampness Syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065089
Enrollment
Unknown
Registered
2022-10-27
Start date
2022-10-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre diabetes

Interventions

Intervention group:Yinling dampness expell Granules+life style
control group:placebo+life style

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of Western medicine for pre diabetes; 2.Patients with suspected pre diabetes still meet the diagnostic criteria after 2 weeks of washout period; 3.Meet the diagnosis of dampness syndrome in traditional Chinese medicine; 4.18 years old < age <= 75 years old; 5.Subjects signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women or women preparing for pregnancy; 2.Allergic constitution or allergy to the components of this traditional Chinese medicine; 3.Serious abnormal liver and kidney function (the elevation of liver enzyme exceeds 2 times or more of the upper limit of normal value; eGFR is less than 25ml/min); 4.Anemia (hemoglobin Hb less than 120g/L) and hypoproteinemia (plasma albumin less than 35g/L); 5.Those who cannot strictly observe and consciously cooperate with the research requirements of this trial. 6.Secondary hyperglycemia, such as taking hormone, Cushing's syndrome, etc; 7.Those who have reached the diagnosis of diabetes; Or there are malignant tumors or mental diseases; Or other serious primary diseases; 8.Previous cardiovascular and cerebrovascular events.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;Postprandial blood glucose;glycosylated hemoglobin;Dampness Syndrome Rating Scale;

Secondary

MeasureTime frame
Fasting insulin;Postprandial insulin;Fasting C-peptide;Postprandial C-peptide;

Countries

China

Contacts

Public ContactWei Hua

Guangdong Provincial Hospital of Chinese Medicine

13829701168@163.com13829701168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026